...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics
【24h】

Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics

机译:预防新生儿B组链球菌疾病:健康维持组织中的成本-效果以及延迟接受出院的新生儿接受产前抗生素治疗的影响

获取原文
           

摘要

Objectives. To estimate the cost and health benefits of implementing a risk factor-based prevention strategy for early-onset neonatal group B streptococcal (GBS) disease, using baseline assumptions and costs from a health maintenance organization. With the risk factor-based strategy, intrapartum antibiotics (IPAs) would be provided to women with fever, prolonged rupture of membranes, or preterm labor. A second objective was to determine the impact of an increased length of stay for well term infants with mothers who received IPAs.Methods. We used decision analysis to compare the costs and benefits of the prevention strategy with usual obstetric practice for a cohort of 100?000 women and their newborn infants. We derived baseline values from a previous study based on chart review and automated cost data from a health maintenance organization in Northern California. In sensitivity analyses, we varied baseline assumptions, including additional costs for observing well term infants who received IPAs.Results. If adherence to guidelines were 100%, 17% of mothers would receive IPAs at a cost of $490?000; $1.6 million would be saved by preventing 66 GBS cases (64% reduction). The net savings would be $1.1 million and 61 life-years. The net cost is sensitive to the cost of caring for well infants who received IPAs. If each term infant of a mother who received IPAs had 1 more day of observation than other term infants, there would be a net cost of $8.1 million; the cost per GBS case prevented would be $120?000 and the cost per life-year saved would be $130?000.Conclusions. Implementation in a health maintenance organization of a risk factor-based strategy to prevent neonatal GBS disease can prevent substantial disease and be cost saving. However, if the length of hospital stay were extended among well term infants whose mothers received IPAs, the strategy would be relatively costly compared with other medical interventions.
机译:目标。使用基线假设和健康维护组织的成本,估算针对早发性新生儿B组链球菌(GBS)疾病实施基于风险因素的预防策略的成本和健康益处。通过基于风险因素的策略,将为发烧,长时间胎膜破裂或早产的妇女提供产时抗生素(IPAs)。第二个目标是确定延长住院时间对患有接受IPAs的母亲的足月婴儿的影响。我们使用决策分析将预防策略的成本和收益与100,000名妇女及其新生儿的常规产科实践进行比较。我们基于图表审查和北加州一家健康维护组织的自动成本数据,从先前的研究中得出了基线值。在敏感性分析中,我们改变了基线假设,包括观察接受IPA的足月婴儿的额外费用。如果100%遵守准则,则有17%的母亲将获得49万美元的《近期行动计划》;通过预防66个GBS案件(减少64%),可以节省160万美元。净节省额为110万美元,使用寿命为61个生命年。净成本对照料好接受IPA的婴儿的成本敏感。如果接受IPAs的母亲的每个足月婴儿的观察天数比其他足月婴儿多1天,那么其净成本将为810万美元;每个预防的GBS案件的成本为120-000美元,每个生命年节省的成本为130-000美元。在健康维护组织中实施基于风险因素的策略来预防新生儿GBS疾病可以预防重大疾病并节省成本。但是,如果延长其母亲接受IPAs的足月婴儿的住院时间,与其他医疗干预措施相比,该策略将相对昂贵。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号